Researchers from the made a strong impact at the 2025 this fall. ASTRO is the premier global gathering for radiation oncology professionals, and this year, the UK Markey Cancer Center team presented a diverse portfolio of innovative studies and clinical advancements.
Key highlights:
- Morgan Levy, MD, radiation oncology resident, received the prestigious ASTRO Breast Cancer Research Foundation Travel Grant, recognizing her contributions to breast cancer research.
- Enes Atici, MD, and Aradhana Kaushal, MD, presented 鈥淚n the Eye of the Beholder鈥, a study focused on improving rural oncology equity through lean process enhancements in uveal melanoma brachytherapy.
- Atici also led a presentation on pituitary adenoma radiosurgery, exploring dosimetry factors linked to post-treatment pituitary function.
- Verny Rodriguez, MD, shared findings from a Phase 2 trial showing that sparing secondary lymphoid organs during lung SBRT significantly reduces immune suppression and improves overall survival.
- Jovan Pierre-Charles, MD, presented research on risk-adapted SBRT for peripherally located lung tumors,emphasizing patient-reported outcomes.
Markey Cancer Center researchers contributed multiple retrospectives and dosimetry studies, including:
- Radiosurgery for intracranial arteriovenous malformations
- Spatially fractionated radiotherapy for unresectable bulky tumors
- Hyperarc stereotactic radiosurgery for ventricular tachycardia
- Radiosurgery for single and multiple brain metastases
These presentations reflect Markey鈥檚 commitment to advancing radiation oncology through patient-centered research, innovative treatment approaches and equitable care delivery.
More information about the ASTRO 2025 meeting, including abstracts and poster presentations, is .